Newsbot

CGE Energy, Inc and Aradatum, Inc 2025 Year End Update

BRIGHTON, Mich, Dec. 30, 2025 (GLOBE NEWSWIRE) -- CGE Energy, Inc. (OTC: CGEI) today announced the issuance of the following year end update letter from its President and Chief Executive Officer, Bryan Zaplitny.

Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California.

Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 12, 2026, at 9:00 am Pacific Standard Time / 12:00 pm Eastern Sta...

Treace to Present at 44th Annual J.P. Morgan Healthcare Conference

PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that John T. Treace, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, beginning at approximately 7:30 am PT.

US-Investmentkonzern von Warren Buffett vor Führungswechsel

NEW YORK (dpa-AFX) - Der legendäre US-Investor Warren Buffett zieht sich in dieser Woche aus dem operativen Tagesgeschäft seines US-Finanz- und Industriekonglomerats Berkshire Hathaway zurück. Die Leitung des Konzerns übernimmt US-Medien zufolge sei...

Tesla’s Vanishing Order Hastens Fall of an $800 Million Fortune

Tesla Inc. once propelled a little-known South Korean family into the ranks of the ultra-rich on a landmark supply deal. But as the contract fell short of expectations, it became a drag on a fortune that was already under pressure — with the full extent only now becoming clear.

Nordea Bank Abp: Repurchase of own shares on 30.12.2025

Nordea Bank AbpStock exchange release – Changes in company’s own shares30.12.2025 at 22.30 EETNordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 30.12.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows:+----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+------...